NCT00495339View on ClinicalTrials.gov

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Conditions
Tuberculosis, Pulmonary
Interventions
DRUG

Levofloxacin

500-1000 mg once a day daily per os with combination of drugs.

Trial Locations (1)

Unknown

Sanofi-Aventis, Moscow

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00495339 - MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis | Biotech Hunter | Biotech Hunter